Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b. [electronic resource]
Producer: 19890522Description: 2771-7 p. digitalISSN:- 0022-1767
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Complement C3-C5 Convertases -- pharmacology
- Complement C3b -- administration & dosage
- Complement C3b Inactivator Proteins -- metabolism
- Complement Factor H
- Complement Pathway, Alternative
- Cytotoxicity, Immunologic
- Elapid Venoms -- administration & dosage
- Humans
- Immunotherapy
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neoplasms -- immunology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.